KRS Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
3,320
-45
-1% -$15.4K 0.56% 31
2026
Q1
$1.18M Sell
3,365
-20
-0.6% -$7.13K 0.73% 29
2025
Q4
$1.11M Sell
3,385
-92
-3% -$29.2K 0.64% 32
2025
Q3
$981K Sell
3,477
-226
-6% -$65.5K 0.59% 35
2025
Q2
$1.03M Buy
3,703
+7
+0.2% +$1.98K 0.69% 32
2025
Q1
$1.15M Sell
3,696
-19
-0.5% -$5.61K 0.92% 25
2024
Q4
$968K Sell
3,715
-242
-6% -$71.8K 0.68% 29
2024
Q3
$1.27M Sell
3,957
-76
-2% -$24.9K 0.93% 22
2024
Q2
$1.26M Sell
4,033
-39
-1% -$11.5K 0.94% 22
2024
Q1
$1.16M Buy
4,072
+802
+25% +$235K 0.93% 25
2023
Q4
$942K Buy
3,270
+420
+15% +$114K 0.88% 26
2023
Q3
$766K Buy
2,850
+147
+5% +$36.7K 0.82% 29
2023
Q2
$600K Buy
2,703
+48
+2% +$11.1K 0.6% 47
2023
Q1
$642K Buy
2,655
+518
+24% +$127K 0.72% 37
2022
Q4
$561K Buy
2,137
+60
+3% +$16.1K 0.77% 43
2022
Q3
$468K Buy
2,077
+93
+5% +$22.5K 0.65% 48
2022
Q2
$482K Buy
1,984
+2
+0.1% +$490 0.69% 44
2022
Q1
$479K Sell
1,982
-47
-2% -$10.8K 0.52% 56
2021
Q4
$456K Buy
+2,029
New +$428K 0.39% 67

Other funds holding AMGN

KRS Capital Management's AMGN Position: Q2 2026 in Review

KRS Capital Management reduced its Amgen (AMGN) stake by 1.3% in Q2 2026, selling an estimated $15.4K and leaving 3,320 shares worth $1.2M. The position accounts for 0.56% of the portfolio, ranked #31.

KRS Capital Management first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.27M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • KRS Capital Management held 3,320 shares of Amgen worth $1.2M as of Q2 2026.
  • KRS Capital Management sold 45 Amgen shares in Q2 2026, an estimated $15.4K.
  • Amgen made up 0.56% of KRS Capital Management's portfolio in Q2 2026, its #31 holding.
  • KRS Capital Management first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • KRS Capital Management's Amgen position peaked at $1.27M in Q3 2024.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.